Lively and in-depth discussions of city news, politics, science, entertainment, the arts, and more.
Hosted by Larry Mantle
Airs Weekdays 10 a.m.-12 p.m.

FDA to tighten its regulations on homeopathic drugs




This picture taken on May 20, 2016 shows tubes of homeopathic granules at Boiron laboratory in Brest, western of France.
This picture taken on May 20, 2016 shows tubes of homeopathic granules at Boiron laboratory in Brest, western of France.
FRED TANNEAU/AFP/Getty Images

Listen to story

16:44
Download this story 8.0MB

On Monday, the Food and Drug Administration announced a new proposal to enforce regulations on homeopathic remedies that are at high risk of causing harm in patients.

The proposal brings a shift to what were previously seen as lax laws for the controversial form of medicine. Homeopathy, which is based on the idea that an intensely diluted form of a substance can help treat the disease that substance causes, has been generally free from FDA crack downs in the past largely due to the fact that no active harmful ingredients make it into the final dilution.

But lack of guidance has led to a number of problems in manufacturing standards, including companies that have marketed products as homeopathic drugs despite containing other harmful substances, and continued criticism from the scientific community over the industry as a whole.

Host Larry Mantle speaks with two experts on the subject and what this means for homeopathic drugs moving forward.

Guests:

Nick Little, vice president and general counsel for the Center for Inquiry, a non-profit organization advocating for science-based policy

Alissa Gould, public relations manager for Boiron, the largest manufacturer of homeopathic medicines, and spokesperson for the American Association of Homeopathic Pharmacists